R15L (p.Arg15Leu) variant of KRT6B (Keratin, type II cytoskeletal 6B)

R15L (p.Arg15Leu) in KRT6B (Keratin, type II cytoskeletal 6B) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.10 / 1. The record also includes population frequency data and structural context.

R15L (p.Arg15Leu) variant details